CLINICAL_TRIALS
trial_result
· 2014-07-02
Clinical Trial Update: High Dose Cyclophosphamide for Treatment of Scleroderma [Phase 3]
Summary
A Phase 3 trial evaluating high-dose cyclophosphamide for systemic sclerosis has completed enrollment and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Scleroderma | Phase 3 | Status: COMPLETED | Results posted: 2014-07-02